408 related articles for article (PubMed ID: 10945317)
1. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the direct and indirect venoconstrictor effects of endothelin-1 and big endothelin-1 in man.
Haynes WG; Moffat S; Webb DJ
Br J Clin Pharmacol; 1995 Oct; 40(4):307-11. PubMed ID: 8554931
[TBL] [Abstract][Full Text] [Related]
3. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
Abernethy DR; Laurie N; Andrawis NS
Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
[TBL] [Abstract][Full Text] [Related]
4. Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans.
Haynes WG; Strachan FE; Gray GA; Webb DJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S40-3. PubMed ID: 8587426
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-induced venoconstriction is unaffected by type 2-diabetes: in vivo effect of histamine on the endothelin action on veins.
Blöchl-Daum B; Vierhapper H; Eichler HG; Waldhäusl W
Arch Int Pharmacodyn Ther; 1992; 316():90-6. PubMed ID: 1530376
[TBL] [Abstract][Full Text] [Related]
6. Vascular effects of endothelin-1 in humans and influence of calcium channel blockade.
Kiowski W; Linder L; Erne P
J Hypertens Suppl; 1994 Jan; 12(1):S21-6. PubMed ID: 8207561
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent modulation of venoconstriction to sarafotoxin S6c in human veins in vivo.
Strachan FE; Haynes WG; Webb DJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S180-2. PubMed ID: 8587356
[TBL] [Abstract][Full Text] [Related]
8. Analysis of responses to big endothelin in the hindquarters vascular bed of the cat.
Tamura DY; Minkes RK; Bellan JA; McMahon TJ; McNamara DB; Kadowitz PJ
Can J Cardiol; 1992 Nov; 8(9):954-60. PubMed ID: 1486546
[TBL] [Abstract][Full Text] [Related]
9. Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans.
Gudmundsdóttir IJ; Megson IL; Kell JS; Ludlam CA; Fox KA; Webb DJ; Newby DE
Circulation; 2006 Oct; 114(15):1625-32. PubMed ID: 17015787
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II evokes potent vasoconstriction in humans in vivo.
Böhm F; Pernow J
Br J Pharmacol; 2002 Jan; 135(1):25-7. PubMed ID: 11786476
[TBL] [Abstract][Full Text] [Related]
11. Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1.
Böhm F; Johansson BL; Hedin U; Alving K; Pernow J
Atherosclerosis; 2002 Jan; 160(1):215-22. PubMed ID: 11755940
[TBL] [Abstract][Full Text] [Related]
12. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
Postma CT; Maessen SM; Thien T; Smits P
Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
[TBL] [Abstract][Full Text] [Related]
13. The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man.
Cockcroft JR; Clarke JG; Webb DJ
Br J Clin Pharmacol; 1991 May; 31(5):521-4. PubMed ID: 1888618
[TBL] [Abstract][Full Text] [Related]
14. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.
Haynes WG; Hand MF; Johnstone HA; Padfield PL; Webb DJ
J Clin Invest; 1994 Oct; 94(4):1359-64. PubMed ID: 7929810
[TBL] [Abstract][Full Text] [Related]
15. [Endothelin-induced vasoconstriction in man: variable modification caused by endothelium-derived relaxing factor, Sodium nitroprusside and calcium antagonists].
Kiowski W; Linder L; Lüscher TF; Bühler FR
Schweiz Med Wochenschr; 1992 Apr; 122(15):559-62. PubMed ID: 1566022
[TBL] [Abstract][Full Text] [Related]
16. Potent vasoconstrictor effects and clearance of endothelin in the human forearm.
Pernow J; Hemsén A; Lundberg JM; Nowak J; Kaijser L
Acta Physiol Scand; 1991 Mar; 141(3):319-24. PubMed ID: 1858504
[TBL] [Abstract][Full Text] [Related]
17. Constriction to ETB receptor agonists, BQ-3020 and sarafotoxin s6c, in human resistance and capacitance vessels in vivo.
Strachan FE; Crockett TR; Mills NL; Gray GA; Webb DJ
Br J Clin Pharmacol; 2000 Jul; 50(1):27-30. PubMed ID: 10886114
[TBL] [Abstract][Full Text] [Related]
18. Human vascular responses to endothelin-1: observations in vivo and in vitro.
Hughes AD; Thom SA; Woodall N; Schachter M; Hair WM; Martin GN; Sever PS
J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S225-8. PubMed ID: 2473321
[TBL] [Abstract][Full Text] [Related]
19. High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.
Wilkinson IB; Affolter JT; de Haas SL; Pellegrini MP; Boyd J; Winter MJ; Balment RJ; Webb DJ
Cardiovasc Res; 2002 Feb; 53(2):341-7. PubMed ID: 11827684
[TBL] [Abstract][Full Text] [Related]
20. Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig.
Hemsén A; Pernow J; Lundberg JM
Acta Physiol Scand; 1991 Mar; 141(3):325-34. PubMed ID: 1858505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
